Literature DB >> 22531395

Infectious complications associated with the use of acellular dermal matrix in implant-based bilateral breast reconstruction.

Joseph L Hill1, Lesley Wong, Pamela Kemper, Jason Buseman, Daniel L Davenport, Henry C Vasconez.   

Abstract

BACKGROUND: The use of acellular dermal matrix (ADM) has become a routine practice in implant-based breast reconstruction. Bilateral mastectomy is becoming more popular in cases of unilateral breast cancer. ADM has been associated with an increased incidence of complications.
METHODS: We identified cases of bilateral implant-based breast reconstruction over a 5-year period. Data collection included medical comorbities, details of operative management, and details of postoperative cancer treatment.
RESULTS: On univariate analysis, the use of ADM (31% vs. 7%, P = 0.018), smoking (37% vs. 13%, P = 0.045), and open wound (55% vs. 13%, P = 0.006) were significantly associated with increased risk of infection. Multivariate analysis revealed open wound as the strongest predictor of infection.
CONCLUSIONS: The use of ADM is associated with an increased risk of infection in bilateral implant-based breast reconstruction. However, it does not appear to be an independent risk factor by itself.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22531395     DOI: 10.1097/SAP.0b013e31823b6ac6

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  13 in total

1.  Use of latissimus dorsi muscle onlay patch alternative to acellular dermal matrix in implant-based breast reconstruction.

Authors:  Jeeyeon Lee; Youngtae Bae
Journal:  Gland Surg       Date:  2015-06

Review 2.  Breast Reconstruction Following Cancer Treatment.

Authors:  Bernd Gerber; Mario Marx; Michael Untch; Andree Faridi
Journal:  Dtsch Arztebl Int       Date:  2015-08-31       Impact factor: 5.594

3.  DermACELL Acellular Dermal Matrix in Oncologic Breast Reconstruction: A Cohort Study and Systematic Review.

Authors:  Austin R Swisher; Mark J Landau; Nikita Kadakia; Stephanie W Holzmer; Hahns Y Kim
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-06-20

4.  Prophylactic antibiotic use in acellular dermal matrix-assisted implant-based breast reconstruction.

Authors:  Fak Mazari; G M Wattoo; N H Kazzazi; K M Kolar; O O Olubowale; C E Rogers; I A Azmy
Journal:  Ann R Coll Surg Engl       Date:  2021-03       Impact factor: 1.951

5.  Comparison of the postoperative incidence rate of capsular contracture among different breast implants: a cumulative meta-analysis.

Authors:  Xing Liu; Liang Zhou; Fuqiang Pan; Yang Gao; Xi Yuan; Dongli Fan
Journal:  PLoS One       Date:  2015-02-13       Impact factor: 3.240

6.  TiLoop® Bra mesh used for immediate breast reconstruction: comparison of retropectoral and subcutaneous implant placement in a prospective single-institution series.

Authors:  Donato Casella; Marco Bernini; Lapo Bencini; Jenny Roselli; Maria Teresa Lacaria; Jacopo Martellucci; Roberto Banfi; Claudio Calabrese; Lorenzo Orzalesi
Journal:  Eur J Plast Surg       Date:  2014-08-03

7.  Subcutaneous Direct-to-Implant Breast Reconstruction: Surgical, Functional, and Aesthetic Results after Long-Term Follow-Up.

Authors:  Marco Bernini; Claudio Calabrese; Lorenzo Cecconi; Caterina Santi; Ulpjana Gjondedaj; Jenny Roselli; Jacopo Nori; Alfonso Fausto; Lorenzo Orzalesi; Donato Casella
Journal:  Plast Reconstr Surg Glob Open       Date:  2016-01-07

8.  Critical Evaluation of Risk Factors of Infection Following 2-Stage Implant-Based Breast Reconstruction.

Authors:  Chao Long; Gloria R Sue; Arhana Chattopadhyay; Eva Huis In't Veld; Gordon K Lee
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-07-05

9.  AlloDerm RTU Integration and Clinical Outcomes When Used for Reconstructive Breast Surgery.

Authors:  Allen Gabriel; G Patrick Maxwell
Journal:  Plast Reconstr Surg Glob Open       Date:  2018-05-18

10.  The use of synthetic mesh in reconstructive, revision, and cosmetic breast surgery.

Authors:  Hilton Becker; Jeffrey G Lind
Journal:  Aesthetic Plast Surg       Date:  2013-07-17       Impact factor: 2.326

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.